Skip to main content
SpringerLink
Log in

Brachytherapy best bet for oesophageal cancer?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. da Silveira EB, Artifon EL.Cost-effectiveness of palliation of unresectable esophageal cancer. Digestive Diseases and Sciences 53: 3103-3111, No. 12, Dec 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brachytherapy best bet for oesophageal cancer?. Pharmacoecon. Outcomes News 571, 7 (2009). https://doi.org/10.2165/00151234-200905710-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905710-00013

Keywords

Search

Navigation